PINK1/Parkin-mediated mitophagy in cardiovascular disease: From pathogenesis to novel therapy

Int J Cardiol. 2022 Aug 15:361:61-69. doi: 10.1016/j.ijcard.2022.05.025. Epub 2022 May 17.

Abstract

Cardiovascular disease(CVD)is one of the predominant causes of death and morbidity. Mitochondria play a key role in maintaining cardiac energy metabolism. However, mitochondrial dysfunction leads to excessive production of ROS, resulting in oxidative damage to cardiomyocytes and contributing to a variety of cardiovascular diseases. In such a case, the clearance of impaired mitochondria is necessary. Currently, most studies have indicated an essential role for mitophagy in maintaining cardiac homeostasis and regulating CVD-related metabolic transition. Recent studies have implicated that PTEN-induced putative kinase 1 (PINK1)/Parkin-mediated mitophagy has been implicated in maintaining cardiomyocyte homeostasis. Here, we discuss the physiological and pathological roles of PINK1/Parkin-mediated mitophagy in the cardiovascular system, as well as potential therapeutic strategies based on PINK1/Parkin-mediated mitophagy modulation, which are of great significance for the prevention and treatment of cardiovascular diseases.

Keywords: Cardiomyocyte; Cardiovascular disease; Mitochondria; Mitophagy; PINK1; Parkin.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cardiovascular Diseases* / metabolism
  • Humans
  • Mitochondria / metabolism
  • Mitophagy*
  • Protein Kinases / metabolism
  • Ubiquitin-Protein Ligases

Substances

  • Ubiquitin-Protein Ligases
  • Protein Kinases